Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kenalog vs Silver Nitrate vs Washcloth Abrasion for Granulation Tissue
NCT02519738Phase 3Terminated
- Sponsor
- University of Michigan
- Start
- Jan 2015
- Primary completion
- Nov 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of triamcinolone acetonide in hypergranulation tissue (3 arms), sponsored by University of Michigan. Primary endpoint: Decrease in Size (mm) of Granulation Tissue at 8 weeks. Started Jan 2015; status: terminated.
02
Drugs
triamcinolone acetonide
03
Conditions
hypergranulation tissue
Beyond the preview
Go deeper on NCT02519738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02519738.